Literature DB >> 20396566

Reduced expression of E-cadherin in human non-small cell lung carcinoma.

Na-Hye Myong1.   

Abstract

PURPOSE: E-cadherin, a calcium-dependent cell to cell adhesion molecule, plays a key role in the maintenance of tissue integrity. Reduction or loss of E-cadherin has been reported to have a role in the development of human malignancies. The expression of E-cadherin was analyzed in human non-small cell lung carcinoma (NSCLC) to elucidate the role in pulmonary carcinogenesis and determine the relationship with several clinicopathological factors and the prognosis.
MATERIALS AND METHODS: Sixty five human cases of NSCLC were evaluated by immunohistochemical analysis for the expression of E-cadherin. The immunostaining results for E-cadherin were semiquantitatively interpreted, as preserved and reduced, in the tumor tissues. The E-cadherin expression was analyzed in relation to several clinicopathological data and the survival. The cell proliferation index of the tumors was evaluated by immunostaining with the Ki-67 antigen.
RESULTS: Reduced E-cadherin expression was found in 51 cases of NSCLC tissues (78.4%) compared to that in the normal controls. Reduced E-cadherin expression was significantly correlated with male smokers and squamous cell type of the cancer, but not with histological grade, TNM stage and survival. The E-cadherin expression showed a weak inverse relationship with the proliferative activity of tumor cells, which was measured using the Ki-67 antigen.
CONCLUSION: Our data support the hypothesis that reduced E-cadherin expression may play a role in the pathogenesis of human NSCLC, which might be associated with the control for cell proliferation.

Entities:  

Keywords:  E-cadherin; Ki-67 antigen; Non-small cell lung carcinoma

Year:  2004        PMID: 20396566      PMCID: PMC2855104          DOI: 10.4143/crt.2004.36.1.56

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  24 in total

1.  Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.

Authors:  S Kase; K Sugio; K Yamazaki; T Okamoto; T Yano; K Sugimachi
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

2.  Differential expression of e-cadherin in normal, metaplastic and dysplastic esophageal mucosa - a putative biomarker.

Authors:  J Jankowski; P Newham; O Kandemir; S Hirano; M Takeichi; M Pignatelli
Journal:  Int J Oncol       Date:  1994-02       Impact factor: 5.650

3.  Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.

Authors:  A C Han; A Peralta-Soler; K A Knudsen; M J Wheelock; K R Johnson; H Salazar
Journal:  Hum Pathol       Date:  1997-06       Impact factor: 3.466

4.  Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis.

Authors:  N Gunji; T Oda; T Todoroki; N Kanazawa; T Kawamoto; K Yuzawa; A Scarpa; K Fukao
Journal:  Cancer       Date:  1998-05-01       Impact factor: 6.860

5.  Expression of E-cadherin in primary and metastatic prostate cancer.

Authors:  L Cheng; M Nagabhushan; T P Pretlow; S B Amini; T G Pretlow
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.

Authors:  Yong Soo Choi; Young Mog Shim; Sang-Hui Kim; Dae Soon Son; Hye-Sook Lee; Gou Young Kim; Joungho Han; Jhingook Kim
Journal:  Eur J Cardiothorac Surg       Date:  2003-09       Impact factor: 4.191

7.  Prognostic value of E-cadherin expression in 413 gastric carcinomas.

Authors:  H E Gabbert; W Mueller; A Schneiders; S Meier; R Moll; W Birchmeier; G Hommel
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

Review 8.  Cadherins in cancer: implications for invasion and metastasis.

Authors:  M Takeichi
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

9.  The role of E-cadherin expression in non-small cell lung cancer.

Authors:  S C Lim; I G Jang; Y C Kim; K O Park
Journal:  J Korean Med Sci       Date:  2000-10       Impact factor: 2.153

10.  E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).

Authors:  B St Croix; C Sheehan; J W Rak; V A Flørenes; J M Slingerland; R S Kerbel
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

View more
  10 in total

1.  Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium.

Authors:  Eugenia C Pacheco-Pinedo; Amy C Durham; Kathleen M Stewart; Ashley M Goss; Min Min Lu; Francesco J Demayo; Edward E Morrisey
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

2.  Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.

Authors:  T Xu; X Liu; L Han; H Shen; L Liu; Y Shu
Journal:  Clin Transl Oncol       Date:  2013-09-10       Impact factor: 3.405

3.  MCAM expression is associated with poor prognosis in non-small cell lung cancer.

Authors:  X Zhang; Z Wang; Y Kang; X Li; X Ma; L Ma
Journal:  Clin Transl Oncol       Date:  2013-06-08       Impact factor: 3.405

4.  Prognostic Significance of Wnt1, Wnt2, E-Cadherin, and β-catenin Expression in Operable Non-small Cell Lung Cancer.

Authors:  Anna Wrona; Aleksandra Sejda; Rafał Dziadziuszko; Jacek Jassem
Journal:  J Histochem Cytochem       Date:  2021-10-19       Impact factor: 2.479

5.  PDCD4 inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling pathway and upregulating Keap1 expression.

Authors:  Soon-Kyung Hwang; Yun-Jeong Jeong; Young-Chae Chang
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

6.  SATB1 protein is associated with the epithelial‑mesenchymal transition process in non‑small cell lung cancers.

Authors:  Natalia Glatzel-Plucinska; Aleksandra Piotrowska; Adam Rzechonek; Marzenna Podhorska-Okolow; Piotr Dziegiel
Journal:  Oncol Rep       Date:  2021-05-06       Impact factor: 3.906

7.  E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux.

Authors:  Oliver Reichel; Doris Mayr; Florian Durst; Alexander Berghaus
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-05       Impact factor: 3.236

8.  Dietary flavonoid myricetin inhibits invasion and migration of radioresistant lung cancer cells (A549-IR) by suppressing MMP-2 and MMP-9 expressions through inhibition of the FAK-ERK signaling pathway.

Authors:  Hye R Kang; Jeong Y Moon; Meran K Ediriweera; Yeon W Song; Moonjae Cho; Dharanibalan Kasiviswanathan; Somi K Cho
Journal:  Food Sci Nutr       Date:  2020-03-09       Impact factor: 2.863

9.  Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer.

Authors:  Judy Yan; Nicholas Wong; Claudia Hung; Wendy Xin-Yi Chen; Damu Tang
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

Review 10.  Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors.

Authors:  Thian-Sze Wong; Wei Gao; Jimmy Yu-Wai Chan
Journal:  Biomed Res Int       Date:  2014-08-13       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.